A new study details a possible solution for fine-tuning inflammation and cellular activity in cardiac recovery — thanks to an antibody initially developed for rheumatoid arthritis.
Antibody ‘road block’ enables fine-tuning for cardiac recovery
A new study details a possible solution for fine-tuning inflammation and cellular activity in cardiac recovery — thanks to an antibody initially developed for rheumatoid arthritis.